Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Looking to earn more? Discover simple ways to integrate money-making activities into your daily routine.
27,728 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Century DeAnna Realty capped a five-year growth sprint with a 110% rise in transactions, leveraging culture-driven M&...
When a CEO sells stock, it invites questions. This guide breaks down Zoom's sold company stock, what it signals about...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
When a major tech name drops, many investors feel the urge to retreat. Yet history shows that this tech stock down mo...
A senior executive at Invesco disclosed a stock sale as the shares jumped about 63%. This article digs into what this...
A retail-tech veteran leads Elevance Health’s push to modernize consumer experience and cost clarity in health benefi...
Utilities are no longer safe havens in 2026 as higher yields and climate liabilities challenge traditional income arg...
During a broad AI stock drawdown, Cathie Wood doubling down on CoreWeave signals a high-conviction bet. This article ...
Tensions over Iran have flipped XRP into a geopolitics-driven asset. As the Iran conflict escalates, traders watch pr...
Credo Technology faces a pivotal Q4 print as analysts and traders dissect margins, inventory builds, and AI demand si...
Mortgage lenders are moving AI from experimentation to enterprise deployment in 2026. Addy AI's Michael Vandi explain...